2,6-dihydroxyanthraquinone has been researched along with daunorubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Hintzpeter, J; Hofman, J; Martin, HJ; Maser, E; Seliger, JM; Wsol, V | 1 |
1 review(s) available for 2,6-dihydroxyanthraquinone and daunorubicin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
1 other study(ies) available for 2,6-dihydroxyanthraquinone and daunorubicin
| Article | Year |
|---|---|
Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
Topics: Anthraquinones; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Emodin; Humans; Molecular Docking Simulation; Oxidoreductases; Protein Kinase Inhibitors | 2016 |